NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Supplement·Evidence index

Lutein and Zeaxanthin: what the published research says

PubMed indexes 5 records that name Lutein and Zeaxanthin together, either in the title or in an interaction, co-administration, or pharmacokinetic context. 3 further sources came from NutriStack’s own review rather than from that query, and are labelled as such. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Lutein and Zeaxanthin. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

8 studies naming Lutein and Zeaxanthin.

Hand-reviewed sources first, then papers naming both substances in the title, then human trials and systematic reviews.

Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.

JAMA ophthalmology · 2022 · PMID 35653117

Multicenter StudyRandomized Controlled TrialResearch Support, N.I.H., Extramural

“Results of this long-term epidemiologic follow-up study of the AREDS2 cohort suggest that lutein/zeaxanthin was an appropriate replacement for beta carotene in AREDS2 supplements. Beta carotene usage nearly doubled the risk of lung cancer, whereas there was no statistically significant increased risk with lutein/zeaxanthin. When compared with beta carotene, lutein/zeaxanthin had a potential beneficial association with late AMD progression.”

Chew et al. · Authors' conclusion

Names both Lutein and Zeaxanthin in its title. Selected by hand during source review for Lutein and Zeaxanthin, rather than by the automated PubMed query.

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

JAMA · 2013 · PMID 23644932

Multicenter StudyRandomized Controlled TrialResearch Support, N.I.H., ExtramuralResearch Support, N.I.H., Intramural

“Addition of lutein + zeaxanthin, DHA + EPA, or both to the AREDS formulation in primary analyses did not further reduce risk of progression to advanced AMD. However, because of potential increased incidence of lung cancer in former smokers, lutein + zeaxanthin could be an appropriate carotenoid substitute in the AREDS formulation.”

Authors' conclusion

Names both Lutein and Zeaxanthin in its title. Selected by hand during source review for Lutein and Zeaxanthin, rather than by the automated PubMed query.

Macular pigment in donor eyes with and without AMD: a case-control study.

Investigative ophthalmology & visual science · 2001 · PMID 11133874

Comparative StudyHuman subjects

“The results are consistent with a theoretical model that proposes an inverse association between risk of AMD and the amounts of L and Z in the retina. The results are inconsistent with a model that attributes a loss of L and Z in the retina to the destructive effects of AMD.”

Bone et al. · Authors' conclusion

Selected by hand during source review for Lutein and Zeaxanthin, rather than by the automated PubMed query. It covers one side of the pair; it is listed as background the reviewer relied on, not as a study of the combination.

Lutein and Zeaxanthin Supplementation Improves Dynamic Visual and Cognitive Performance in Children: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study.

Advances in therapy · 2024 · PMID 38363462

Randomized Controlled Trial

“Supplementing LZ resulted in increased MPOD levels, along with increased serum levels of L, Z, and BDNF. These changes were associated with improved visual and cognitive performances and reduction in eye strain and eye fatigue in the children receiving LZ gummies. The investigational product was safe and well tolerated.”

Parekh et al. · Authors' conclusion

Names both Lutein and Zeaxanthin in its title.

Lutein, zeaxanthin, and meso-zeaxanthin supplementation attenuates inflammatory cytokines and markers of oxidative cardiovascular processes in humans.

Nutrition, metabolism, and cardiovascular diseases : NMCD · 2024 · PMID 38890092

Randomized Controlled Trial

“Our data show that L, Z, & MZ supplementation results in decreased serum IL-1β, TNF-α, and OxLDL. This suggests that these carotenoids are acting systemically to attenuate oxidative lipid products and inflammation, thus reducing their contribution to atherosclerotic plaque formation.”

Stringham et al. · Authors' conclusion

Names both Lutein and Zeaxanthin in its title.

The effects of lutein/ zeaxanthin (Lute-gen(®)) on eye health, eye strain, sleep quality, and attention in high electronic screen users: a randomized, double-blind, placebo-controlled study.

Frontiers in nutrition · 2025 · PMID 39963662

“The results from this study provide support for the beneficial effects of 6 months of lutein and zeaxanthin supplementation on regular users of electronic screens. Compared to the placebo, there were improvements in several ophthalmic examinations for dry eyes and visual health. However, these findings were not corroborated by group differences in the administered self-report measures.”

Lopresti et al. · Authors' conclusion

Names both Lutein and Zeaxanthin in its title.

Lutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration-Neurodegenerative Disease.

Nutrients · 2022 · PMID 35215476

ReviewHuman subjects

“It has been shown that supportive therapy with lutein and zeaxanthin can have a beneficial effect in delaying the progression of eye diseases such as age-related macular degeneration (AMD) and cataracts. This article presents the current state of knowledge on the role of lutein and zeaxanthin, especially from human studies targeting their metabolism and bioavailability, with recommendations to consume xanthophyll-rich foods.”

Mrowicka et al. · From the abstract

Names both Lutein and Zeaxanthin in its title.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Lutein, Zeaxanthin, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.